• 대한족부족관절학회지
• /
• 제26권2호
• /
• pp.71-77
• /
• 2022

Purpose: This study sought to investigate the appropriate indications for intra-articular injection of hyaluronic acid in ankle osteoarthritis, its efficacy at each stage of osteoarthritis and to compare the efficacy related differences at each stage. Materials and Methods: A retrospective study was conducted from January 2016 to September 2019 on 43 patients (50 cases) diagnosed with ankle arthritis and given intra-articular injection of hyaluronic acid. Patients were classified according to the modified Takakura ankle osteoarthritis stages. Stage 2 comprised 24 cases; stage 3A, 15 cases; stage 3B, 8 cases; and stage 4, 3 cases. The clinical evaluation was carried out using the visual analogue scale (VAS), American Orthopaedic Foot and Ankle Society (AOFAS) score, and the Foot and Ankle Outcome Score (FAOS). The patients' satisfaction with the injection was evaluated at 1 year after injection. A radiographic evaluation was performed to gauge the progression of osteoarthritis before and after the injection. Results: The VAS, AOFAS score, and FAOS at 3 months and 1 year after injection showed statistically significant improvements compared to those before the injection. There was a significant difference in the VAS for each stage over time; however, this was not the case with the AOFAS score and the FAOS. A significant improvement of the VAS after injection was seen only in stage 3A when compared with the other stages. The overall satisfaction rate with the injection was 90%. There were no ankle osteoarthritic stage changes in the serial follow-up radiograph. Conclusion: Intra-articular injection of hyaluronic acid resulted in a significant clinical improvement up to 1 year after the injection. Therefore, the intra-articular injection of hyaluronic acid could be a treatment option for ankle osteoarthritis.

• 성인간호학회지
• /
• 제16권3호
• /
• pp.493-501
• /
• 2004

Purpose: The purpose of this study was 1) to classify the stage of adoption 2) to compare the decisional balance and confidence by stage of adoption 3) to identify factors influenced the stage of adoption for breast self exam. Method: A comparative study using a survey method with convenience sample of 143 women was used. Decisional balance and confidence was measured using the CHBMS-K. Stage of adoption for BSE was measured by a single item modified by the researchers based on the Rakowski et al (1992). Result: 1) The number of women in each stage of adoption for BSE was as follows; maintenance phase, 7.7% (n=11), action phase, 49.0% (n=70), contemplation phase, 35.0% (n=50) and pre- contemplation phase, 8.4%(n=12). 2) The mean difference in the decisional balance (F=4.32, p=.006) and confidence (F=13.85, p=.000) according to the stage of BSE adoption was statistically significant. 3) Prevention education and confidence accounted for 32% of variance in BSE. Conclusion: Assessment of decisional balance and stage of adoption for BSE can guide planning for cancer prevention education. We must educate women to have confidence in BSE. Further, it is important to urge women to continually practice BSE.

• 한국통신학회논문지
• /
• 제27권1B호
• /
• pp.24-33
• /
• 2002

비동기 W-CDMA를 위한 셀 탐색 방법은 슬롯 동기 과정(stage 1), 그룹 확인 및 프레임 동기 과정(stage 2), 긴 코드 동기 과정(stage 3)으로 구성되어있다. 특히 이동국에 전력이 처음 들어왔을 때 수행되는 셀 탐색을 초기 셀 탐색이라 한다. 초기 셀 탐색에서는 이동국의 초기 주파수 오차와 시간 오차에 의해 성능이 저하된다. 본 논문에서는 이러한 동기 오류 중 초기에 클럭 발생기에 의해 유발되는 시간 오차를 보상해주기 위해 시간 동기 블록을 적용한 초기 셀 탐색 방법을 제안한다. 제안된 방식에서는 시간 동기 블록이 슬롯 동기 과정에서 할당된 슬롯 시작점을 기준으로 동기 추적 과정을 수행하므로 stage 2와 stage 3에서의 시간 오차를 보상하게 된다. 제안된 초기 셀 탐색 방법을 사용할 경우, 시스템의 시간 오차가 ${\pm}T_c$/2일 때, 기존 방식보다 최대 1.5dB의 성능 향상을 얻을 수 있었다.

• 한국게임학회 논문지
• /
• 제4권3호
• /
• pp.65-70
• /
• 2004

모바일 기기에 대한 다양한 멀티미디어 기능의 요구로 입체감을 제공하는 3차원 그래픽 가속기의 구현이 절실한 상황이다. 하지만 다양한 멀티미디어 기능을 가져야 하는 최근의 휴대폰의 경향과 상대적으로 발전이 더딘 배터리의 문제를 생각할 때 3차원 그래픽 가속기의 저전력화는 필수적이라고 할 수 있다. 이에 본 논문에서는 내장형 3차원 그래픽 가속기 각 내부모듈별 전력소비를 측정하고 이를 내부 그래픽 처리과정과 함께 분석하였다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권2호
• /
• pp.887-890
• /
• 2014

This study was undertaken to compare surgical outcomes and survival rates of patients with the 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIA1 versus IIA2 cervical cancer treated with radical hysterectomy and pelvic lymphadenectomy (RHPL). Patients with stage IIA cervical cancer undergoing primary RHPL between January 2003 and December 2012 at Chiang Mai University Hospital were retrospectively reviewed. The analysis included clinicopathologic variables, i.e. nodal metastasis, parametrial involvement, positive surgical margins, deep stromal invasion (DSI)), lymph-vascular space invasion (LVSI), adjuvant treatment, and 5-year survival. The chi square test, Kaplan-Meier method and log-rank test were used for statistical analysis. During the study period, 133 women with stage IIA cervical cancer, 101 (75.9 %) stage IIA1, and 32 (24.1 %) stage IIA2 underwent RHPL. The clinicopathologic variables of stage IIA1 compared with stage IIA2 were as follows: nodal metastasis (38.6% vs 40.6%, p=0.84), parametrial involvement (10.9% vs 15.6%, p=0.47), positive surgical margins (31.7% vs 31.3%, p=1.0), DSI (39.6% vs 53.1%, p=0.18), LVSI (52.5% vs 71.9%, p=0.05) and adjuvant radiation (72.3% vs 84.4%, p=0.33). With a median follow-up of 60 months, the 5-year disease-free survival (84.6% vs 88.7%, p=0.67) and the 5-year overall survival (83.4% vs 90.0%, P=0.49) did not significantly differ between stage IIA1 and stage IIA2 cervical cancer. In conclusion, patients with stage IIA1 and stage IIA2 cervical cancer have comparable rates of locoregional spread and survival. The need for receiving adjuvant radiation was very high in both substages. The revised 2009 FIGO system did not demonstrate significant survival differences in stage IIA cervical cancer treated with radical hysterectomy. Concurrent chemoradiation should be considered a more suitable treatment for patients with stage IIA cervical cancer.

• 상하수도학회지
• /
• 제8권2호
• /
• pp.1-11
• /
• 1994

This study was conducted to develop a new RBC process available for the effective removal of organic matters and nitrogen in sewage. The RBC process for the oxidation organic compounds and nitrification was designed to occur at the 1st-stage and next-stage RBC respectively. Then nitrified water was recycled to the denitrifying RBC located at the lower part of the 1st-stage RBC. Some results were summarized as follows. 1. The loading limitation was represented as $60g{\cdot}COD/gm^2/day$ in experiment of simultaneous removal of organic matter and nitrogen. The maxmum COD % removal was 85% at the load $35g{\cdot}COD/m^2/day$. 2. The $NO_3-N$ % removal was approximately 80% at the load $60g{\cdot}COD/m^2/day$ and the maximum $NO_3-N$ remaval rate was $3.9g{\cdot}COD/m^2/day$ and the overall C/N ratio of 11.0 as required to achive 80% of $NO_3-N$% removal. 3.$NO_3-N$ removal rate was rapidly decreased above the load $7g{\cdot}NH_4{^+}-N/m^2/day$ and the maximum $NO_3-N$ removal rate was $3.7g{\cdot}NO_3-N/m^2/day$. 4. Irrespective of the recycle ratio, the COD % removal at the system of 2-stage RBC unit was nearly constant as 89% while the maximum one in the 1st-stage unit was 77% in the case of 50% recycle. 5. The maximum COD % removal in the 3-stage RBC system was 93% while 1st-stage one being 80%, under the $NH_4{^+}-N$ load of $7.4g/m^2{\cdot}d$. Also maximum percentage of nitrification and denitrification was 69% and 41% respectively, under the same $NH_4{^+}-N$ load.

• 대한산업공학회지
• /
• 제41권5호
• /
• pp.425-438
• /
• 2015

This study proposes a three-stage model of R&BD performance which captures commercialization outcomes as well as conventional R&D performance. The model is composed of three factors : inputs (R&D budgets and researchers), outputs (patents and papers), and outcomes (technical fees, products sales, and cost savings). Three stages are defined for each transformation process between the three factors : efficiency stage from input to output (stage 1), effectiveness stage from output to outcome (stage 2), and productivity stage from input to outcome (stage 3). The performance of each stage is measured by data envelopment analysis (DEA). DEA is a non-parametric efficiency measurement technique that has widely been used in R&D performance measurement. We measure the performance of 171 projects of 6 public R&BD programs managed by Seoul Business Agency using the proposed three-stage model. In order to provide a balanced and holistic view of R&BD performance, the R&BD performance map is also constructed based on performance of efficiency and productivity stages.

• 대한임상검사과학회지
• /
• 제50권3호
• /
• pp.284-288
• /
• 2018

Scuttle fly의 중추신경계는 알 시기와 애벌레 1령 시기는 애벌레의 크기가 너무 작아서 중추신경계를 분리하기 곤란하여 채취하지 못하여 형태를 관찰할 수 없었고, 애벌레 시기 2령(instar) 2~3일은 윗부분의 뇌가 좌측과 우측으로 분리되어 있었고 아래 부분에는 식도하신경절에 의해 복신경색이 "ㄴ"자 모양으로 연결되어 있었다. 애벌레 3령 3~5일은 2령에 비해 중추신경계가 약간 커져 있는 것을 제외하고는 동일한 특성을 가지고 있었다. 번데기 시기에는 중추신경계가 앞쪽 머리에 위치하고 있었고, 번데기 1~3일에는 애벌레 3령 시기의 모양과 형태가 거의 비슷했으며, 번데기 4~6일에는 좌측과 우측으로 분리되어 있었던 뇌 조직이 점점 밀착되어 합쳐져 있었으며 가장자리에 자리 잡은 시엽도 점점 발생하여 완성된 형태로 만들어지고 있었다. 번데기 7~9일에는 시엽 가장자리에 안구 색소(eyeball pigment)가 관찰되었고 식도하신경절이 뇌 조직과 결합되면서 복신경색 조직과 분리되기 시작하고 신경섬유(nerve fiber)도 많이 증가되고 있었다. 번데기 10~12일에는 중추신경계의 뇌와 복신경색이 뚜렷하게 분리되었고 시엽의 안구 색소도 진한 갈색으로 뚜렷이 관찰되었다. 번데기 13~15일에는 분리된 뇌와 복신경색 조직이 가느다란 신경섬유에 의해 겨우 연결되어 있었고 복신경색 조직도 위와 아래로 두 개로 분리되기 시작하였고 무수히 많은 신경섬유가 생성되어 있었다. 그리고 성충 시기에는 번데기 13~15일 시기와 거의 비슷한 특징을 가지고 있고, 특히 중추신경계 조직인 머리 부분의 뇌 조직과 가슴 앞쪽 부분의 복신경색 조직이 위치해 있는 것을 관찰하였다.

• Radiation Oncology Journal
• /
• 제9권1호
• /
• pp.103-109
• /
• 1991

I, II기 intermediate grade악성 임파종에서 방사선 치료의 역할을 극인하기 위하여 서울대학교 병원 치료 방사선과에서 치료받은 162예의 방사선 치료 성적을 분석하였다. 초기의 치료 실패 양상 이 확인 가능한 68 예 중 38.2%는 조사야 내에서 61.8%는 조사야 밖에서 치료 실패 또는 재발 하였다. I기에서는 조사야 내 및 외에서 발생한 치료 실패 양상은 국소 조사야 치료시 각각 30.0%와 70.0%였고, 확대 조사야 치료시는 각각 43.8% 와 56.2%였다. II기에서는 각각 16.7% 와 83.3% 및 41.7%와 58.3%였다. 5년 무병 생존율은 전 환자에서 48.1%였고, I기 및 II기에서 각각 56.3%와 40.4%로 병기에 따른 유의한 차이가 있었다. 10cm 이상의 종괴나 전신적 증상은 무병 생존율에 영향을 미치지 못하였다. 방사선 치료 범위가 큰 경우에 5년 무병 생존율이 양호하였고 특히 I기에서는 유의하였다. 재발후에 시행한 전신 화학요법의 효과를 감안한 5년 생존율은 I, II기에서 각각 65.3% 및 52.2%였으며 병기에 따른 유의한 차이는 없었다. 따라서 5년 무병 생존율을 향상시키기 위해서는 원발 병소와 인접한 임파절 부위를 포함하는 화대 조사야로 치료할 필요가 있으며 재발된 경우에는 전신 화학 요법이 유용할 것으로 시사된다.

• Journal of Gastric Cancer
• /
• 제20권3호
• /
• pp.233-244
• /
• 2020

Purpose: For unresectable or initially metastatic gastric cancer, conversion surgery (CVS), after systemic chemotherapy, has received attention as a treatment strategy. This study evaluated the prognostic value of ypTNM stage and the oncologic outcomes in patients receiving CVS. Materials and Methods: A retrospective review of clinicopathologic findings and oncologic outcomes of 116 patients who underwent CVS with curative intent, after combination chemotherapy, between January 2000 and December 2015, has been reported here. Results: Twenty-six patients (22.4%) underwent combined resection of another organ and 12 patients received para-aortic lymphadenectomy (10.3%). Pathologic complete remission (CR) was confirmed in 11 cases (9.5%). The median overall survival (OS) and disease-free survival (DFS) times were 35.0 and 21.3 months, respectively. In multivariate analysis, ypTNM stage was the sole independent prognostic factor for DFS (P=0.042). Tumors invading an adjacent organ or involving distant lymph nodes showed better survival than those with peritoneal seeding or solid organ metastasis (P=0.084). Kaplan-Meier curves showed that the 3-year OS rate of patients with pathologic CR and those with CR of the primary tumor but residual node metastasis was 81.8% and 80.0%, respectively. OS was 65.8% for stage 1 patients, 49.8% for those at stage 2, and 36.3% for those at stage 3. Conclusions: The ypTNM staging is a significant prognostic factor in patients who underwent CVS for localized unresectable or stage IV gastric cancers. Patients with locally advanced but unresectable lesions or with tumors with distant nodal metastasis may be good candidates for CVS.